Retinoid X receptor (RXR) within the RXR-retinoic acid receptor heterodimer binds its ligand and enhances retinoid-dependent gene expression

Molecular and Cellular Biology

Volumn 17, Issue 2, 1997, Pages 644-655

  Minucci, Saverio ^a   Leid, Mark ^b   Toyama, Reiko ^a   Saint Jeannet, Jean Pierre ^a   Peterson, Valerie J ^b   Horn, Valerie ^a   Ishmael, Jane E ^b   Bhattacharyya, Nisan ^a   Dey, Anup ^a   Dawid, Igor B ^a   Ozato, Keiko ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR;

ARTICLE; BINDING AFFINITY; CARCINOMA CELL; DNA FOOTPRINTING; GENE EXPRESSION; GENETIC TRANSCRIPTION; LIGAND BINDING; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; RECEPTOR BINDING; RECEPTOR OCCUPANCY; REPORTER GENE;

EID: 0031038518     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.2.644     Document Type: Article

References (67)

1. Allan, G. F., X. Leng, S. Y. Tsai, N. L. Weigel, D. P. Edwards, M.-J. Tsai, and B. W. O'Malley. 1992. Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. J. Biol. Chem. 267:19513-19520.
2. Allan, G. F., X. Leng, S. Y. Tsai, N. L. Weigel, D. P. Edwards, M.-J. Tsai, and B. W. O'Malley. 1992. Ligand-dependent conformational changes in the progesterone receptor are necessary for events that follow DNA binding. Proc. Natl. Acad. Sci. USA 89:11750-11754.
3. Allegretto, E. A., M. R. McClurg, S. B. Lazarchik, D. L. Clemm, S. A. Kerner, M. G. Elgort, M. F. Boehm, S. K. White, J. W. Pike, and R. H. Heyman. 1993. Transactivation properties of retinoic acid and retinoid X receptors in mammalian cells and yeast. J. Biol. Chem. 268:26625-26633.
4. Allenby, G., M. T. Bocquel, M. Saunders, S. Kazmer, J. Speck, M. Rosenberger, A. Lovey, P. Kastner, J. F. Grippo, P. Chambon, and A. Levin. 1993. Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. Proc. Natl. Acad. Sci. USA 90:30-34.
5. Angulo, A., C. Suto, R. A. Heyman, and P. Ghazal. 1996. Characterization of the sequences of the human cytomegalovirus enhancer that mediate differential regulation by natural and synthetic retinoids. Mol. Endocrinol. 10: 781-793.
6. Apfel, C., M. Kamber, M. Klaus, P. Mohr, S. Keidel, and P. K. LeMotte. 1995. Enhancement of HL-60 differentiation by a new class of retinoids with selective affinity on retinoid X receptor. J. Biol. Chem. 270:30765-30772.
7. Barettino, D., M. M. Vivanco Ruiz, and H. G. Stunnenberg. 1994. Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor. EMBO J. 13:3039-3049.
8. Beekman, J. M., G. F. Allan, S. Y. Tsai, M.-J. Tsai, and B. W. O'Malley. 1993. Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain. Mol. Endocrinol. 7:1266-1274.
9. Bhat, M. K., C. Parkinson, P. McPhie, C. M. Liang, and S. Y. Cheng. 1993. Conformational changes of human β1-thyroid hormone receptor induced by binding of 3,3′,5-triiodo-L-thyronine. Biochcm. Biophys. Res. Commun. 195: 385-392.
10. Blanco, J. C., A. Dey, M. Leid, S. Minucci, B. K. Park, P. Jurutka, M. Haussler, and K. Ozato. 1996. Inhibition of ligand-induced promoter occupancy in vivo by a dominant negative RXR. From Genes to Cell 1:209-221.
11. Brooks III, S. C., S. Kazmer, A. A. Levin, and A. Yen. 1996. Myeloid differentiation and retinoblastoma phosphorylation changes in HL-60 cells induced by retinoic acid receptor- and retinoid X receptor-selective retinoic acid analogs. Blood 87:227-237.
12. Chambon, P. 1996. A decade of molecular biology of retinoid receptors. FASEB J. 10:940-954.
13. Chen, D., and R. M. Evans. 1995. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457.
14. Chen, J. Y., J. Clifford, C. Zusi, J. E. Starrett, D. Tortolani, J. Ostrowski, P. Reczek, P. Chambon, and H. Gronemeyer. 1996. Two distinct actions of retinoid-receptor ligands. Nature 382:819-822.
15. Clifford, J., H. Chiba, D. Sobieszczuk, D. Metzger, and P. Chambon. 1996. RXRα null F9 EC cells are resistant to the differentiation, anti-proliferative and apoptotic effects of retinoids. EMBO J. 15:4142-4155.
16. Davis, K. D., T. J. Borrodin, S. J. D., J. D. Winkler, and M. A. Lazar. 1994. Endogenous retinoid X receptors can function as hormone receptors in pituitary cells. Mol. Cell. Biol. 14:7105-7110.
17. de The, H., M. M. Vivanco-Ruiz, H. Stunnenberg, and A. Dejean. 1990. Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene. Nature 343:177-180.
18. Dey, A., S. Minucci, and K. Ozato. 1994. Ligand-dependent occupancy of the retinoic acid receptor-β2 promoter in vivo. Mol. Cell. Biol. 12:3590-3599.
19. Dey, A., and K. Ozato. Genomic footprinting of retinoic acid regulated promoters in embryonal carcinoma cells. Methods, in press.
20. Durand, B., M. Saunders, C. Gaudon, B. Roy, R. Losson, and P. Chambon. 1994. Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO J. 13:5370-5382.
21. Durston, A. J., J. P. Timmermans, W. J. Hage, H. F. Hendriks, N. J. de Vries, M. Heideveld, and P. D. Nieuwkoop. 1989. Retinoic acid causes an anteroposterior transformation in the developing central nervous system. Nature 340:140-144.
22. Forman, B., E. Goode, J. Chen, A. Oro, D. J. Bradley, T. Perlmann, D. Noonan, L. T. Burka, T. McMorris, W. W. Lamph, and R. M. Evans. 1995. Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 81:687-693.
23. Forman, B. M., K. Umesono, J. Chen, and R. M. Evans. 1995. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81:541-550.
24. Fritsch, M., C. M. Leary, J. D. Furlow, H. Ahrens, T. J. Schuh, G. C. Mueller, and J. Gorski. 1992. A ligand-induced conformational change in the estrogen receptor is localized in the steroid binding domain. Biochemistry 31:5303-5311.
25. Glass, C. K. 1994. Differential recognition of target genes by nuclear receptors monomers, dimers, and heterodimers. Endocrinol. Rev. 15:391-407.
26. Heyman, R. A., D. J. Mangelsdorf, J. A. Dick, R. B. Stein, G. Eichele, R. M. Evans, and C. Thaller. 1992. 9-Cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68:397-406.
27. Hörlein, A. J., A. M. Näär, T. Heinzel, J. Torchia, B. Gloss, R. Kurokawa, A. Ryan, Y. Kamei, M. Soderstrom, C. K. Glass, and M. G. Rosenfeld. 1995. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-403.
28. Horn, V., S. Minucci, V. Ogryzko, E. Adamson, B. Howard, A. Levin, and K. Ozato. 1996. RAR and RXR selective ligands cooperatively induce apoptosis and neuronal differentiation in P19 embryonal carcinoma cells. FASEB J. 10:1071-1077.
29. Kastner, P., M. Mark, and P. Chambon. 1995. Nonsteroid nuclear receptors: what are genetic studies telling us about their roles in real life? Cell 83:859-871.
30. Keaveney, M., and H. Stunnenberg. 1995. Retinoic acid receptors, p. 187-242. In P. A. Baeuerle (ed.), Inducible gene expression, vol. II. Birkhäuser, Boston, Mass.
31. Keidel, S., P. LeMotte, and C. Apfel. 1994. Different agonist- and antagonist-induced conformational changes in retinoic acid receptors analyzed by prolease mapping. Mol. Cell. Biol. 14:287-298.
32. Kersten, S., M. I. Dawson, B. A. Lewis, and N. Noy. 1996. Individual subunits of heterodimers comprised of retinoic acid and retinoid X receptors interact with their ligands independently. Biochemistry 35:3816-3824.
33. Kliewer, S. A., K. Umesono, D. J. Noonan, R. A. Heyman, and R. M. Evans. 1992. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358: 771-774.
34. Kruyt, F. A., G. Folkers, C. E. van den Brink, and P. T. van der Saag. 1992. A cyclic AMP response clement is involved in retinoic acid-dependent RAR beta 2 promoter activation. Nucleic Acids Res. 20:6393-6399.
35. Kurokawa, R., J. DiRenzo, M. Boehm, J. Sugarman, B. Gloss, M. G. Rosenfeld, R. A. Heyman, and C. K. Glass. 1994. Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding. Nature 371:528-531.
36. Kurokawa, R., M. Soderstrom, A. Hörlein, S. Halachmi, M. Brown, M. G. Rosenfeld, and C. K. Glass. 1995. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377:451-454.
37. La Vista-Picard, N., P. Hobbs, M. Pfahl, M. I. Dawson, and M. Pfahl. 1996. The receptor-DNA complex determines the retinoid response: a mechanism for the diversification of the ligand signal. Mol. Cell. Biol. 16:4137-4146.
38. Leblanc, B., and H. G. Stunnenberg. 1995. 9-Cis retinoic acid signaling: changing partners causes some excitement. Genes Dev. 9:1811-1816.
39. Lehmann, J. M., L. Jong, A. Fanjul, J. F. Cameron, X.-P. Lu, P. Haefner, M. I. Dawson, and M. Pfahl. 1992. Retinoids selective for retinoid X receptor response pathways. Science 258:1944-1946.
40. Leid, M. 1994. Ligand-induced alteration of the protease sensitivity of retinoid X receptor alpha. J. Biol. Chem. 269:14175-14181.
41. Leng, X., J. Blanco, S. Y. Tsai, K. Ozato, B. W. O'Malley, and M.-J. Tsai. 1995. Mouse retinoid X receptor contains a separable ligand-binding and transactivation domain in its E region. Mol. Cell. Biol. 15:255-263.
42. Leng, X., S. Y. Tsai, B. W. O'Malley, and M.-J. Tsai. 1993. Ligand-dependent conformational changes in thyroid hormone and retinoic acid receptors are potentially enhanced by heterodimerization with retinoic X receptor. J. Steroid Biochem. Mol. Biol. 46:643-661.
43. Levin, A. A., L. J. Sturzenbecker, S. Kazmer, T. Bosakowski, C. Huselton, G. Allenby, J. Speck, C. Kratzeisen, M. Rosenberger, A. Lovey, and J. F. Grippo. 1992. 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR. Nature 355:359-361.
44. Lotan, R., M. I. Dawson, C.-C. Zou, L. Jong, D. Lotan, and C.-P. Zou. 1995. Enhanced efficiency of combinations of retinoic acid and retinoid X receptor-selective retinoids and α-interferon in inhibition of cervical carcinoma cell proliferation. Cancer Res. 55:232-236.
45. Mangelsdorf, D. J., C. Thummel, M. Beato, P. Herrlich, G. Schütz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, and R. Evans, 1995. The nuclear hormone receptor superfamily: the second decade. Cell 83:835-840.
46. Mangelsdorf, D. J., and R. M. Evans. 1995. The RXR heterodimers and orphan receptors. Cell 83:841-850.
47. Minucci, S., D. J. Zand, A. Dey, M. S. Marks, T. Nagata, J. F. Grippo, and K. Ozato. 1994. Dominant negative retinoid X receptor β inhibits retinoic acid-responsive gene regulation in embryonal carcinoma cells. Mol. Cell Biol. 14:360-372.
48. Minucci, S., V. Botquin, Y. I. Yeom, A. Dey, I. Sylvester, D. J. Zand, K. Ohbo, K. Ozato, and H. R. Schöler. 1996. Retinoic acid-mediated down-regulation of Oct3/4 coincides with the loss of promoter occupancy in vivo. EMBO J. 15:888-899.
49. Minucci, S., J. P. Saint-Jeannet, R. Toyama, G. Scita, L. M. De Luca, M. Taira, A. A. Levin, K. Ozato, and I. B. Dawid. 1996. Retinoid X receptor-selective ligands produce malformations in Xenopus embryos. Proc. Natl. Acad. Sci. USA 93:1803-1807.
50. Minucci, S., and K. Ozato. 1996. Retinoid receptors in transcriptional regulation. Curr. Opin. Genet. Dev. 6:567-574.
51. Nagy, L., V. A. Thomázy, G. Shipley, L. Fesüs, W. Lamph, R. A. Heymao, R. A. Chandraratna, and P. J. Davies. 1995. Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol. Cell. Biol. 15:3540-3551.
52. Perlmann, T., and L. Jansson. 1995. A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1. Genes Dev. 9:769-782.
53. Rosen, E. D., A. L. O'Donnell, and R. J. Koenig. 1992. Ligand-dependent synergy of thyroid hormone and retinoid X receptors. J. Biol. Chem. 267: 22010-22013.
54. Roy, B., R. Taneja, and P. Chambon. 1995. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor α (RARα)-, RARβ-, or RARγ-selective ligand in combination with a retinoid X receptor-specific ligand. Mol. Cell Biol. 15:6481-6487.
55. Schulman, I. G., H. Juguilon, and R. M. Evans. 1996. Activation and repression by nuclear hormone receptors: hormone modulates an equilibrium between active and repressive states. Mol. Cell. Biol. 16:3807-3813.
56. Simons, S. S., F. D. Sistare, and P. K. Chakraborti. 1989. Steroid binding activity is retained in a 16-kDa fragment of the steroid binding domain of rat glucocorticoid receptor. J. Biol. Chem. 264:14493-14497.
57. Sporn, M. B., A. B. Roberts, and D. S. Goodman (ed.). 1994. The retinoids, 2nd ed. Raven, New York, N.Y.
58. Sucov, H. M., K. K. Murakami, and R. M. Evans. 1990. Characterization of an autoregulated response element in the mouse retinoic acid receptor β gene. Proc. Natl. Acad. Sci. USA 87:5392-5396.
59. Taneja, R., B. Roy, J.-L. Plassat, C. F. Zusi, J. Ostrowski, P. R. Reczek, and P. Chambon. 1996. Cell-type and promoter-context dependent redundancies for RARβ2 and Hoxa-1 activation in F9 and P19 cells can be artefactually generated by gene knockouts. Proc. Null. Acad. Sci. USA, 93:6197-6202.
60. Tsai, M.-J., and B. W. O'Malley. 1994. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63: 451-486.
61. Valcarcel, R., H. Holtz, C. G. Jemenez, D. Barettino, and H. G. Stunnenberg. 1994. Retinoid-dependent in vitro transcription mediated by the RXR/RAR heterodimer. Genes Dev. 8:3068-3079.
62. Vegeto, E., G. F. Allan, W. T. Schrader, M.-J. Tsai, D. P. McDonnell, and B. W. O'Malley. 1992. The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor. Cell 69:703-713.
63. Willy, P. J., K. Umesono, E. S. Ong, R. M. Evans, R. A. Heyman, and D. J. Mangelsdorf. 1995. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev. 9:1033-1045.
64. Xian, J.-H., B. Durand, P. Chambon, and J. J. Voorhees. 1995. Endogenous RAR/RXR heterodimers are the major functional forms regulating retnoid-responsive elements in adult human keratinocyles. J. Biol. Chem. 270:3001-3011.
65. Yang, Y., S. Minucci, K. Ozato, R. A. Heyman, and J. D. Ashwell. 1995. Efficient inhihition of activation-induced Fas tigand up-regulation and T cell apoptosis by retinoids requires occupancy of both retinoid X receptors and retinoic acid receptors. J. Biol. Chem. 270:18672-18677.
66. Yao, T. B., B. M. Forman, Z. Jiang, L. Cherbas, J. D. Chen, M. McKeown, and R. M. Evans. 1993. Functional ecdysone receptor is the product of EcR and Ultraspiracle genes. Nature 366:476-179.
67. Zhang, X.-K., J. Lehmann, B. Hoffmann, M. I. Dawson, J. Cameron, G. Graupner, H. T., P. Tran, and M. Pfahl. 1992. Homodimer formation of retinoid X receptor induced by 9-cis-retinoic acid. Nature 358:587-591.